Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$15.93 - $22.26 $53,317 - $74,504
-3,347 Reduced 10.18%
29,534 $652,000
Q1 2024

May 14, 2024

BUY
$15.55 - $19.42 $511,299 - $638,549
32,881 New
32,881 $601,000
Q3 2023

Nov 13, 2023

SELL
$15.0 - $20.71 $532,200 - $734,790
-35,480 Reduced 45.84%
41,928 $826,000
Q2 2023

Aug 14, 2023

SELL
$10.84 - $15.43 $8,563 - $12,189
-790 Reduced 1.01%
77,408 $1.17 Million
Q1 2023

May 12, 2023

SELL
$9.32 - $12.58 $147,628 - $199,267
-15,840 Reduced 16.84%
78,198 $895,000
Q4 2022

Feb 13, 2023

BUY
$6.82 - $12.07 $641,339 - $1.14 Million
94,038 New
94,038 $867,000
Q1 2020

May 13, 2020

SELL
$16.59 - $34.94 $170,113 - $358,274
-10,254 Closed
0 $0
Q4 2019

Feb 18, 2020

BUY
$22.24 - $27.56 $228,048 - $282,600
10,254 New
10,254 $257,000

Others Institutions Holding PETQ

About PetIQ, Inc.


  • Ticker PETQ
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 29,312,800
  • Market Cap $908M
  • Description
  • PetIQ, Inc. operates as a pet medication and wellness company in the United States and internationally. It operates in two segments, Products and Services. The company offers Rx pet medications, which include flea and tick control, heartworm preventatives, arthritis, thyroid, diabetes and pain treatments, antibiotics, and other specialty medicat...
More about PETQ
Track This Portfolio

Track Algert Global LLC Portfolio

Follow Algert Global LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Algert Global LLC, based on Form 13F filings with the SEC.

News

Stay updated on Algert Global LLC with notifications on news.